P3.01-111 Efficacy and Safety of Cytotoxic Drug Chemotherapy After First-Line EGFR-TKI in Elderly Patients with NSCLC Harboring Sensitive EGFR Mutations

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2018年第10期|共1页
• 作者

  Y. Yamada; H. Imai; T. Sugiyama; H. Minemura; K. Kaira; K. Kanazawa; T. Kasai; T. Kaburagi; K. Minato;

  展开▼
• 作者单位

  Respiratory Medicine Ibaraki Prefectural Central Hospital and Cancer Center;

  Department of Respiratory Medicine Gunma Prefectural Cancer Center;

  Division of Thoracic Oncology Tochigi Cancer Center;

  Department of Pulmonary Medicine Fukushima Medical University;

  Oncology Clinical Development Gunma University Graduate School of Medicine;

  Department of Pulmonary Medicine Fukushima Medical University;

  Division of Thoracic Oncology Tochigi Cancer Center;

  Respiratory Medicine Ibaraki Prefectural Central Hospital and Cancer Center;

  Respiratory Medicine Gunma Prefectural Cancer Center;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词